TSX closed
Loading marketsโ€ฆ

Advertisement

Stocks

Why TelyRx Holdings Inc. stock is plummeting today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:TELY.TO

Get TELY alerts:

Photos provided by Pexels

TelyRx Holdings Inc. saw a significant drop in its stock price, closing down 6.12% in the latest trading session.

In the latest market session, TelyRx Holdings Inc. (TELY.TO) experienced a notable decline, closing at CA$2.30, down 6.12%. This downturn raises questions about the company's current performance and investor sentiment.

Advertisement

TelyRx Holdings Inc.

TELY.TO

Full stock page โ†’

TELY.TO

TelyRx Holdings Inc.

Source:WealthAwesomeWealthAwesome
โ†“ $1.10 (-31.43%)
107 day period
$2.20$2.85$3.50Apr 8Jun 24Sep 10

Market cap

$63.82M

52W high

$4.25

52W low

$2.00

1W change

-4.00%

Analyst Price Targets

Based on analyst covering TELY

๐Ÿ“ˆ

Wall Street analysts forecast TELY stock price to rise 150.0% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$6.00

+150.0% Upside

Current Price

C$2.40

Last close

Compare analyst targets across the TSX & TSXV โ†’

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on TELY's historical volatility

HistoricalForecast68%95%
C$0.75C$2.34C$3.93C$5.52C$7.10C$8.69TodayMay 1Jul 8Sep 10Oct 23Dec 6Jan 18

30-Day Vol

99.8%

Annualized

90-Day Vol

95.3%

Annualized

Trend (90d)

+17.9%

Annualized drift

90d Mean

C$2.56

Expected price

HorizonExpected68% Range (1ฯƒ)
30 trading daysC$2.45C$1.74 โ€“ C$3.46
60 trading daysC$2.50C$1.54 โ€“ C$4.08
90 trading daysC$2.56C$1.41 โ€“ C$4.65

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯƒ, 95% band = ยฑ2ฯƒ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should be cautious as TelyRx Holdings Inc. faces challenges, including a widening net loss despite revenue growth. Understanding the implications of these financial results is crucial for making informed decisions.

TelyRx Holdings Inc. suffers a 6.12% drop in one trading day.

The stock's decline comes amid increasing revenues but persistent losses, highlighting the volatility in TelyRx's financial performance.

Bull case

Despite the recent drop, TelyRx has shown impressive revenue growth year-over-year, which suggests there may be potential for recovery and future profitability.

Bear case

However, the widening net loss raises concerns about the company's financial health. This situation could deter investors and lead to further declines in stock price.

Understanding the Decline

Advertisement

On the latest trading day, TelyRx Holdings Inc. saw its stock price decrease significantly, closing at CA$2.30. The 6.12% drop raises concerns among investors about the company's financial trajectory, especially given the recent earnings reports that indicate a widening net loss despite a notable increase in revenue.

Financial Performance Overview

TelyRx reported a revenue increase to CA$19.4 million for Q1 2026, up from CA$6.9 million in Q1 2025. However, the net loss for the same period widened to CA$4.7 million, which may have contributed to the stock's decline. Investors should closely monitor these financial metrics as they reflect the company's operational challenges. For more details, visit our TelyRx stock page.

Market Sentiment and Future Outlook

The market's reaction to TelyRx's financial results suggests a cautious sentiment among investors. While the revenue growth is promising, the persistent losses could lead to further volatility in the stock price. Investors are encouraged to stay informed about future earnings reports and market developments to better assess the company's potential. For ongoing updates, check our TelyRx stock insights.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile โ†’

โœ… Reviewed by Certified Financial Professionals

This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

๐Ÿ“Š Data AccuracyVerified sources
๐Ÿ‡จ๐Ÿ‡ฆ Canadian FocusLocal expertise
๐Ÿ” Fact-CheckedEditorial review

โš ๏ธ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: June 12, 2026
Last Updated: June 12, 2026
PARTNER SPOTLIGHT

Blue Cross Lifeยฎ Term Life Insurance

Affordable term life coverage in Canada โ€” get a free quote in seconds, no credit card required.

  • โœ“Coverage from $100,000 to $5 million, terms of 10โ€“30 years
  • โœ“10% off first-year premiums when couples apply together
  • โœ“Fully digital application โ€” many qualify without a medical exam

Sponsored links

Advertisement